Among them, the false positive rates of CYFRA21-1, ProGRP, and HE4 in patients with CKD stage 3-5 were all above 60%, which was significantly higher than that of healthy controls and CKD stage 2. This evidence concerns the gene GRP and chronic kidney disease.